RPG LIFESCIENCES

about 7 years ago
No image

RPG Lifesciences, formerly known as Searle (India) is a pharma company producing a wide range of quality and affordable medicines in Global Generics and Synthetic API. The company had a poor Q3FY17 performance, beginning right for the net sales, which was down 11% (YoY) at Rs.64.5 crore. Net profit was down 89% at Rs.55 lakh.

The main reason for this is that in current Q3, the inventory held has gone up 67% and this has affected the total costs structure – it was at 98.5% of total income v/s 93% (YoY).

EBITDA came in 37% lower at Rs.5 crore and margins slipped from 10.96% to 7.58%.

The only redeeming part of the numbers – 9MFY17 net profit is at Rs.21 crore, already much ahead of FY16 net profit of Rs.12 crore.  Annualised EPS is at Rs.17 (FV of Rs.8).

Articles you may also like

Popular Comments

No comment posted for this article.